Nuclear translocation of the membrane oxoeicosanoid/androgen receptor, OXER1: Possible mechanisms involved
Molecular and Cellular Endocrinology · 2024-12 · 594 · 112357
DOI: 10.1016/j.mce.2024.112357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2024-12. Verfasst von Panagiotis Malamos und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Endocrinology, School of Medicine, University of Crete, Voutes Campus, 70013, Heraklion, Crete, Greece. Hauptthemen laut MEDLINE: Receptors, Androgen, Cell Nucleus, Receptors, Eicosanoid, Cricetulus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: State Scholarships Foundation, Hellenic Foundation for Research and Innovation.
Abstract (Originalsprache)
OXER1, the receptor for the arachidonic acid metabolite 5-οxo-eicosatetraenoic acid (5-oxo-ETE), has been reported to also bind and mediate the membrane-initiated actions of androgens. Indeed, androgens antagonize the 5-oxo-ETE effects through OXER1, affecting a number of signaling pathways and inhibiting cancer cell proliferation and migration. OXER1, being a GPCR, was classically described to be localized in the plasma membrane. However, for numerous GPCRs, there is now strong evidence that they can be also found in other cellular compartments, including the nucleus. The aim of the present work was to investigate OXER1's possible localization in the nucleus and identify the mechanism(s) involved. For this purpose, we verified OXER1's nuclear presence by immunofluorescence and western blot, in whole cells and nuclei of two different prostate cancer cell lines (DU-145 and LNCaP) and in CHO cells transfected with a GFP labelled OXER1, both in untreated and OXER1 ligands' treated cells. Mutated, OXER1-tGFP expressing, CHO cells were used to verify that OXER1 agonist (5-oxo-ETE) binding is necessary for OXER1 nuclear translocation. NLS sequences were in silico identified, and a specific inhibitor, as well as, specific importins' siRNAs were also utilized to explore the mechanism involved. Moreover, we examined the role of palmitoylation in OXER1 nuclear translocation by in silico identifying possible palmitoylation sites and using a palmitoylation inhibitor. Our results clearly show that OXER1 can be localized in the nucleus, in an agonist-dependent manner, that is inhibited by androgens. We also provide evidence for two possible mechanisms for its nuclear trafficking, that involve receptor palmitoylation and importin-mediated cytoplasmic-nuclear transport. In our knowledge, it is the first time that a membrane androgen receptor is identified into the nucleus, suggesting an alternative, more direct, mode of action, involving nuclear mechanisms. Therefore, our findings provide new insights on androgen-mediated actions and androgen-lipid interactions, and reveal new possible therapeutic targets, not only for cancer, but also for other pathological conditions in which OXER1 may have an important role.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Experimental Endocrinology, School of Medicine, University of Crete, Voutes Campus, 70013, Heraklion, Crete, Greece.
- Laboratory of Biochemistry, School of Medicine, University of Crete, Voutes Campus, 70013, Heraklion, Crete, Greece.
- Laboratory of Pharmacology, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, 54124, Greece.
- Laboratory of Experimental Endocrinology, School of Medicine, University of Crete, Voutes Campus, 70013, Heraklion, Crete, Greece. Electronic address: kampam@uoc.gr.
Förderung
- State Scholarships Foundation
- Hellenic Foundation for Research and Innovation
Zitieren
APA
Malamos, P., Kalyvianaki, K., Panagiotopoulos, A. A., Vogiatzoglou, A. P., Tsikalaki, A. A., Katifori, A., Polioudaki, H., Darivianaki, M. N., Theodoropoulos, P. A., Panagiotidis, C. A., Notas, G., Castanas, E., & Kampa, M. (2024). Nuclear translocation of the membrane oxoeicosanoid/androgen receptor, OXER1: Possible mechanisms involved. Molecular and Cellular Endocrinology, 594, 112357. https://doi.org/10.1016/j.mce.2024.112357
Vancouver
Malamos P, Kalyvianaki K, Panagiotopoulos AA, Vogiatzoglou AP, Tsikalaki AA, Katifori A, et al. Nuclear translocation of the membrane oxoeicosanoid/androgen receptor, OXER1: Possible mechanisms involved. Molecular and Cellular Endocrinology. 2024;594:112357. doi:10.1016/j.mce.2024.112357
BibTeX
@article{Malamos2024,
author = {Malamos, Panagiotis and Kalyvianaki, Konstantina and Panagiotopoulos, Athanasios A and Vogiatzoglou, Amalia P and Tsikalaki, Athanasia Artemis and Katifori, Anastasia and Polioudaki, Hara and Darivianaki, Maria N and Theodoropoulos, Panayiotis A and Panagiotidis, Christos A and Notas, George and Castanas, Elias and Kampa, Marilena},
title = {Nuclear translocation of the membrane oxoeicosanoid/androgen receptor, OXER1: Possible mechanisms involved},
journal = {Molecular and Cellular Endocrinology},
year = {2024},
volume = {594},
pages = {112357},
doi = {10.1016/j.mce.2024.112357}
}
EUVIMED